BARONE, Ines
 Distribuzione geografica
Continente #
NA - Nord America 4.208
EU - Europa 3.129
AS - Asia 350
AF - Africa 120
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 7
SA - Sud America 6
Totale 7.838
Nazione #
US - Stati Uniti d'America 4.071
UA - Ucraina 1.165
DE - Germania 666
AT - Austria 478
SE - Svezia 338
IT - Italia 299
TR - Turchia 151
CA - Canada 132
CN - Cina 127
SN - Senegal 120
FI - Finlandia 59
BE - Belgio 48
IN - India 41
FR - Francia 27
EU - Europa 18
GB - Regno Unito 18
IR - Iran 10
NL - Olanda 9
AU - Australia 7
RU - Federazione Russa 6
SA - Arabia Saudita 6
MX - Messico 5
BR - Brasile 4
CH - Svizzera 3
BG - Bulgaria 2
CZ - Repubblica Ceca 2
EE - Estonia 2
HK - Hong Kong 2
KR - Corea 2
PL - Polonia 2
PT - Portogallo 2
AZ - Azerbaigian 1
BD - Bangladesh 1
EC - Ecuador 1
ES - Italia 1
ID - Indonesia 1
IL - Israele 1
IM - Isola di Man 1
JP - Giappone 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MK - Macedonia 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
SG - Singapore 1
TH - Thailandia 1
Totale 7.838
Città #
Chandler 791
Jacksonville 710
San Mateo 430
Dearborn 365
Vienna 356
Roxbury 165
Lawrence 163
Izmir 136
Dakar 120
Des Moines 110
Ottawa 108
Rende 94
Inglewood 89
Brooklyn 64
Ashburn 63
Ann Arbor 62
Bremen 62
Helsinki 59
Wilmington 59
Brussels 48
Grafing 48
Beijing 46
Florence 39
Cambridge 37
Redwood City 24
Toronto 22
San Francisco 21
Hanover 17
Augusta 12
Jinan 12
Falls Church 11
Hefei 11
Monmouth Junction 10
Seelze 9
Norwalk 8
Kocaeli 7
Leawood 7
Mountain View 7
Boardman 6
Chicago 6
Hebei 6
Kunming 6
Ningbo 6
Riyadh 6
Washington 6
Ardabil 5
Bari 5
Cosenza 5
Esslingen am Neckar 5
Falkenstein 5
Lamezia Terme 5
Nanjing 5
Rome 5
San Giuliano Milanese 5
Trebaseleghe 5
Zhengzhou 5
Frankfurt am Main 4
London 4
Milan 4
Nanchang 4
Naples 4
Palermo 4
Sydney 4
Amsterdam 3
Böblingen 3
Castrovillari 3
Catanzaro 3
Fano 3
Ferentino 3
Fuzhou 3
Gunzenhausen 3
Haikou 3
Livorno 3
Los Angeles 3
Naaldwijk 3
New Delhi 3
San Jose 3
Bangalore 2
Bianco 2
Bisignano 2
Bologna 2
Brno 2
Canberra 2
Casal Di Principe 2
Castrolibero 2
Catania 2
Costa Mesa 2
Curtarolo 2
Formia 2
Fremont 2
Groningen 2
Guangzhou 2
Hangzhou 2
Houston 2
Kish 2
Lincoln 2
Montelavar 2
Mumbai 2
Noicattaro 2
Pozzuoli 2
Totale 4.615
Nome #
Conditional expression of Ki-RasG12V in the mammary epithelium of transgenic mice induces estrogen receptor alpha (ERα)-positive adenocarcinoma 119
Androgens inhibit aromatase expression through DAX-1: disclosing the molecular link between hormone balance and leydig cancer development. 109
Aromatase Inhibitor Resistance in Breast Cancer: a Potential Role for Cytokine Signaling Network 95
Leptin and Notch Signaling Cooperate in Sustaining Glioblastoma Multiforme Progression 94
Collaboration of AR and ERα in conferring resistance to an aromatase inhibitor 91
Activated Farnesoid X Receptor inhibits growth of tamoxifen-resistant breast cancer cells. 89
Leptin Modulates Exosome Biogenesis in Breast Cancer Cells: an Additional Mechanism in Cell-to-Cell Communication 83
Glucocorticoid Receptor as a Potential Target to Decrease Aromatase Expression and Inhibit Leydig Tumor Growth 82
Estrogen Receptor-Positive Breast Cancer Cells Drive CAFs to Secrete Leptin and Support Tumor Invasiveness 80
Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy 80
Phosphodiesterase 5 (PDE5) Expression and Function in Breast Cancer Stroma: an Attractive Opportunity for Targeted Therapy 80
Impact of Vigorous-Intensity Physical Activity on Body Composition Parameters, Lipid Profile Markers, and Irisin Levels in Adolescents: A Cross-Sectional Study. 78
Activation of Farnesoid X Receptor Impairs The Tumor-Promoting Function of Breast Cancer-Associated Fibroblasts 74
Adherence to the Mediterranean diet pattern among university staff: a cross-sectional web-based epidemiological study in Southern Italy 74
Endemic goiter and iodine prophylaxis in Calabria, a region of Southern Italy: Past and present 73
Benzofuran-2-acetic ester derivatives induce apoptosis in breast cancer cells by upregulating p21Cip/WAF1 gene expression in p53-independent manner 71
Mammary Epithelium-Specific Conditional Expression of Human Mutant Ki-Ras in Mice Generates Estrogen Receptor Alpha (ER)-Positive Mammary Adenocarcinomas 71
Mutations in the estrogen receptor alpha hormone binding domain promote stem cell phenotype through notch activation in breast cancer cell lines 69
Androgens inhibit aromatase expression through DAX-1: insights into the molecular link between hormone balance and Leydig cancer development 68
Leptin Modulates Exosome Biogenesis in Breast Cancer Cells: An Additional Mechanism in Cell-to-Cell Communication 67
Omega-3 DHA- and EPA-dopamine conjugates induce PPARγ-dependent breast cancer cell death through autophagy and apoptosis 67
Adipocyte-derived extracellular vesicles promote breast cancer cell malignancy through HIF-1α activity 67
Antiproliferative and autophagic effects of omega-3 EPA and DHA-dopamine conjugates in human breast cancer cells. 66
Role of Phosphodiesterase 5 (PDE5) in Breast Cancer Stroma: Implications for Targeted Therapy 65
Evidences that leptin upregulates E-cadherin expression in breast cancer and promotes tumor cell growth and progression 64
A new role of leptin as amplifier of estrogen signaling in breast cancer. 64
Obesity, leptin and breast cancer: Epidemiological evidence and proposed mechanisms 64
AR collaborates with ERα in aromatase inhibitor-resistant breast cancer 63
Activated Farnesoid X Receptor Inhibits Growth of Tamoxifen-Resistant MCF-7 Breast Cancer Cells, through down-Regulation of HER2 Expression. 63
Leptin Receptor as a Potential Target to Inhibit Human Testicular Seminoma Growth 63
Estrogens and PTP1B function in a novel pathway to regulate aromatase enzymatic activity in breast cancer cells 62
Oldenlandia Diffusa extracts exert antiproliferative and apoptotic effects on human breast cancer cells through ERα/Sp1-mediated p53 activation 61
Human sperm express a functional androgen receptor: effects on PI3K/Akt pathway 60
Impact of Mediterranean Diet Food Choices and Physical Activity on Serum Metabolic Profile in Healthy Adolescents: Findings from the DIMENU Project 60
Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines 59
DAX-1, as an androgen-target gene, inhibits aromatase expression: a novel mechanism blocking estrogen-dependent breast cancer cell proliferation 59
Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines 59
N-Eicosapentaenoyl Dopamine, a Conjugate of Dopamine and Eicosapentaenoic Acid (EPA), Exerts Anti-inflammatory Properties in Mouse and Human Macrophages 59
The Role of PPARγ Ligands in Breast Cancer: from Basic Research to Clinical Studies 59
Identification of novel 2-(1 H-indol-1-yl)-benzohydrazides CXCR4 ligands impairing breast cancer growth & motility 58
Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter 58
DAX-1 at the Crossroads Between Androgens and Aromatase: A Novel Mechanism in the Inhibition of Estrogen-Dependent Cancer Cell Proliferation 58
N-heterocyclic carbene complexes of silver and gold as novel tools against breast cancer progression 58
Development of a Leptin Antagonist Peptide: Implications for Breast Cancer 57
May tumor microenvironment cooperate with a mutant ERalpha to promote breast cancer progression? 57
Activated Farnesoid X Receptor inhibits growth of tamoxifen-resistant breast cancer cells 56
Molecola sintetica antagonista della leptina e uso farmeceutico 56
Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression 55
Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity 55
Phosphodiesterase 5 (PDE5) is highly expressed in cancer-associated fibroblasts and enhances breast tumor progression 55
A novel interplay between AR and DAX-1 controls aromatase expression in estrogen-dependent cancers 54
AR/ER coactivator squelcing contributes to the inhibition of estrogen-dependent cyclin D1 expression in breast cancer 54
Farnesoid X Receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through down-regulation of HER2 expression 54
Role of Farnesoid X Receptor Activation in Counteracting Tumor-promoting Functions of Cancer-Associated Fibroblasts in Breast Cancers 53
Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathway 52
Evidence for enhanced exosome production in aromatase inhibitor-resistant breast cancer cells 52
Modulating Tumor-Associated Macrophage polarization by synthetic and natural PPARγ ligands as a potential target in breast cancer 52
Evidences that leptin upregulates E-cadherin expression in breast cancer: effects on tumor growth and progression 51
Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity. 51
A Palladium-Catalyzed Carbonylation Approach to Eight-Membered Lactam Derivatives with Antitumor Activity 50
Therapeutic potential of leptin receptor modulators 50
Potential antioxidant and anti-inflammatory properties of serum from healthy adolescents with optimal mediterranean diet adherence: findings from DIMENU cross-sectional study 50
Leptin, obesity and breast cancer: progress to understanding the molecular connections 49
Estrogen Receptor-β, through Sp1, Recruits a Corepressor Complex to the Estrogen Receptor-α Gene Promoter in Breast Cancer Cells 49
Leptin Signaling Contributes to Aromatase Inhibitor Resistant Breast Cancer Cell Growth and Activation of Macrophages 49
RUOLO DELLE VARIANTI DELLA PROTEINA DI MATRICE DI HIV-1 P17 SULLE CELLULE DI TUMORE MAMMARIO 48
Leptin mediates tumor-stromal interactions that promote the invasive growth of breast cancer cells 48
Knockdown of Leptin Receptor Affects Macrophage Phenotype in the Tumor Microenvironment Inhibiting Breast Cancer Growth and Progression 48
Expression and Function of Phosphodiesterase Type 5 in Human Breast Cancer Cell Lines and Tissues: Implications for Targeted Therapy 47
Activated Farnesoid X Receptor Inhibits Growth of Tamoxifen-Resistant MCF-7 Breast Cancer Cells, through down-Regulation of HER2 Expression. 47
Molecola sintetica antagonista della leptina e uso farmaceutico 47
Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation 47
Breast cancer cells expressing the K303R estrogen (ER)-alpha- mutant are resistant to an aromatase inhibitor. 47
FXR ligands, by interfering with tumor/microenvironment crosstalk, inhibit breast tumor growth and progression. 47
Farnesoid X receptor in human malignancies: an overview 47
Nutrition Education Program and Physical Activity Improve the Adherence to the Mediterranean Diet: Impact on Inflammatory Biomarker Levels in Healthy Adolescents From the DIMENU Longitudinal Study 47
Mechanisms of divergent effects of activated peroxisome proliferator-activated receptor-γ on mitochondrial citrate carrier expression in 3T3-L1 fibroblasts and mature adipocytes 46
Natural and synthetic PPARγ ligands in tumor microenvironment: a new potential strategy against breast cancer 46
Rapid estradiol/ER{alpha} signaling enhances aromatase enzymatic activity in breast cancer cells 45
Effect of sildenafil on human aromatase activity: From in vitro structural analysis to catalysis and inhibition in cells 45
The Multifaceted Mechanism of Leptin Signaling within Tumor Microenvironment in Driving Breast Cancer Growth and Progression 45
Phosphodiesterase type 5 promotes the invasive potential of breast cancer cells through Rho GTPase activation. 45
n–3 Polyunsaturated Fatty Acid Amides: New Avenues in the Prevention and Treatment of Breast Cancer 45
Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor alpha and its phosphorylation at serine 305 44
Evidence that estradiol through non genomic loop, downregulates PTP1B and enhances aromatase activity in MCF-7 cells 44
Leptin increases HER2 protein levels through a STAT3-mediated up-regulation of Hsp90 in breast cancer cells. 44
The biology of exosomes in breast cancer progression: Dissemination, immune evasion and metastatic colonization 44
Fas ligand in TM4 cells is up-regulated by estradiol through Estrogen Receptor alpha interaction with Sp-1 43
Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth 43
Collaboration of AR and ER in Hormone Resistance and Estrogen Action. 43
K303/S305 Residues of Estrogen Receptor Alpha: New Insights in Aromatase Inhibitor Resistance. 43
Evidences that leptin upregulates E-cadherin gene expression in breast cancer and promotes tumor cell growth and progression 43
Monitoring the effects of iodine prophylaxis in the adult population of southern Italy with deficient and sufficient iodine intake levels: a cross-sectional, epidemiological study 42
Evidence that estradiol, through a short non genomic loop, downregulates PTB1B and enhances aromatase activity in MCF7 cells 42
PI3-kinase/Akt pathway is involved in the short non genomic autocrine loop between 17-β estradiol and aromatase activity in MCF-7 cells. 42
Molecular mechanism through which leptin upregulates e-cadherin expression and influences breast cancer cell growth and progression 42
. A novel model of estrogen receptor (ER) α-positive mestastatic breast cancer 42
Evidences that leptin upregulates E-cadherin expression in breast cancer: effects on tumor growth and progression 42
A novel leptin antagonist peptide inhibits breast cancer growth in vitro and in vivo 42
Phosphorylation processes controlling aromatase activity in breast cancer: an update 41
Totale 5.787
Categoria #
all - tutte 43.649
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.649


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019181 0 0 0 0 0 1 1 2 7 31 137 2
2019/20201.532 145 143 8 152 92 367 119 185 30 28 161 102
2020/20211.291 173 8 159 162 13 163 27 166 70 169 51 130
2021/20222.024 28 278 24 143 217 64 12 475 38 14 289 442
2022/20232.143 270 240 71 219 263 177 69 262 231 58 157 126
2023/2024582 177 73 123 70 119 20 0 0 0 0 0 0
Totale 8.129